{"gao_id": "GAO-15-471", "published": "2015-06-25T12:00:00Z", "released": "2015-07-27T08:00:00Z", "summary": "", "title": "Prescription Drugs: More DEA Information about Registrants' Controlled Substances Roles Could Improve Their Understanding and Help Ensure Access", "topics": ["Pharmacy", "Health Care", "Controlled substances", "Prescription drugs", "Drug enforcement", "Criminal investigations", "Internal controls", "Substance abuse", "Law enforcement", "Communication", "Pharmaceutical industry"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-15-471", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-15-471-highlights.pdf"}, {"title": "Full Report (91 pages)", "url": "https://www.gao.gov/assets/gao-15-471.pdf"}, {"title": "Accessible PDF (98 pages)", "url": "https://www.gao.gov/assets/680/671562.pdf"}]}